Li Peng

5.6k total citations · 2 hit papers
135 papers, 3.7k citations indexed

About

Li Peng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Li Peng has authored 135 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 48 papers in Cancer Research and 17 papers in Oncology. Recurrent topics in Li Peng's work include Cancer-related molecular mechanisms research (30 papers), RNA modifications and cancer (21 papers) and MicroRNA in disease regulation (17 papers). Li Peng is often cited by papers focused on Cancer-related molecular mechanisms research (30 papers), RNA modifications and cancer (21 papers) and MicroRNA in disease regulation (17 papers). Li Peng collaborates with scholars based in China, United States and Germany. Li Peng's co-authors include Guan‐Cheng Li, Xiaoqing Yuan, Binyuan Jiang, Chaoyang Zhang, Xuedong Zhou, Nan Zhou, Haiwei Yang, Jie Han, Pengchao Li and Jingzi Wang and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Li Peng

126 papers receiving 3.7k citations

Hit Papers

Circular RNA circ-ITCH inhibits bladder cancer progressio... 2018 2026 2020 2023 2018 2022 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression
    2018 398 citations Li Peng et al. profile →
  2. FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations
    2022 260 citations Nan Zhou, Xiaoqing Yuan et al. Nucleic Acids Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Peng China 34 2.7k 1.9k 448 286 238 135 3.7k
Masakatsu Takanashi Japan 22 2.8k 1.0× 1.8k 0.9× 231 0.5× 271 0.9× 141 0.6× 60 3.5k
Liuqing Yang China 30 3.7k 1.4× 2.6k 1.3× 606 1.4× 489 1.7× 216 0.9× 84 4.9k
Xue Gao China 33 2.3k 0.9× 1.5k 0.8× 241 0.5× 431 1.5× 312 1.3× 106 3.8k
Haiwei Yang China 28 2.8k 1.1× 1.8k 1.0× 272 0.6× 362 1.3× 330 1.4× 92 3.8k
Yunpeng Zhang China 32 2.1k 0.8× 1.7k 0.9× 239 0.5× 190 0.7× 157 0.7× 94 3.0k
Zhen Wang China 28 1.6k 0.6× 1.3k 0.7× 193 0.4× 406 1.4× 232 1.0× 138 2.6k
Damjan Glavač Slovenia 39 3.1k 1.2× 2.2k 1.2× 569 1.3× 599 2.1× 433 1.8× 143 5.0k
Jie Ding China 34 2.3k 0.9× 1.7k 0.9× 528 1.2× 506 1.8× 401 1.7× 120 3.9k

Countries citing papers authored by Li Peng

Since Specialization
Citations

This map shows the geographic impact of Li Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Peng more than expected).

Fields of papers citing papers by Li Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Peng. The network helps show where Li Peng may publish in the future.

Co-authorship network of co-authors of Li Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Li Peng. A scholar is included among the top collaborators of Li Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Peng. Li Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Nan, Li Peng, Tong Yin, et al.. (2025). FerrDb V3: expanding the manually curated resource for regulators and disease associations from ferroptosis to regulated cell death. Nucleic Acids Research. 54(D1). D572–D582. 1 indexed citations
2.
Liu, Jun, Guangjie Liu, Huibin Kang, et al.. (2025). Rh-relaxin-2 attenuates oxidative stress and neuronal apoptosis via ERK-nNOS-NO pathway after germinal matrix hemorrhage in rats. Fluids and Barriers of the CNS. 22(1). 8–8. 3 indexed citations
3.
4.
Liu, Jun, Ke Ji, Hao Long, et al.. (2024). Dysregulation of phosphoenolpyruvate carboxykinase in cancers: A comprehensive analysis. Cellular Signalling. 120. 111198–111198. 7 indexed citations
5.
Han, Xiaohu, Xue Fang, Li Peng, et al.. (2024). Disruption of bacterial biofilms by a green synthesized artemisinin nano-copper nanomaterial. Metallomics. 16(7). 2 indexed citations
6.
7.
8.
Peng, Li, Nan Zhou, Chaoyang Zhang, Guan‐Cheng Li, & Xiaoqing Yuan. (2022). eccDNAdb: a database of extrachromosomal circular DNA profiles in human cancers. Oncogene. 41(19). 2696–2705. 28 indexed citations
9.
Zhou, Nan, Xiaoqing Yuan, Zhiyu Zhang, et al.. (2022). FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Research. 51(D1). D571–D582. 260 indexed citations breakdown →
10.
Qiu, Yuntan, Meng Meng, Jingyuan Zhang, et al.. (2021). RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma. Molecular Therapy — Nucleic Acids. 27. 241–255. 7 indexed citations
11.
12.
Hu, Yilin, Ying Feng, Yuyan Chen, et al.. (2020). SNHG16 / miR‐605‐3p / TRAF6 /NF‐κB feedback loop regulates hepatocellular carcinoma metastasis. Journal of Cellular and Molecular Medicine. 24(13). 7637–7651. 32 indexed citations
13.
Peng, Li, Binyuan Jiang, Xiaoqing Yuan, et al.. (2018). Super-Enhancer–Associated Long Noncoding RNA HCCL5 Is Activated by ZEB1 and Promotes the Malignancy of Hepatocellular Carcinoma. Cancer Research. 79(3). 572–584. 109 indexed citations
14.
Zhang, Xingmei, Li Peng, Yue Chen, et al.. (2018). Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells. Molecular Therapy — Nucleic Acids. 10. 438–449. 34 indexed citations
15.
Sun, Ruili, Binyuan Jiang, Shujuan Fang, et al.. (2016). Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial–mesenchymal transition. Molecular BioSystems. 12(3). 952–962. 83 indexed citations
16.
Yuan, Xiaoqing, Li Peng, Wenjing Zeng, et al.. (2016). DNMT3A R882 Mutations Predict a Poor Prognosis in AML. Medicine. 95(18). e3519–e3519. 42 indexed citations
17.
Zhou, Hao, Xin Che, Guochen Bao, et al.. (2016). Design, synthesis, and protein methyltransferase activity of a unique set of constrained amine containing compounds. Bioorganic & Medicinal Chemistry Letters. 26(18). 4436–4440. 6 indexed citations
18.
Zhou, Zhongwei, et al.. (2015). Retrospective Study on Multidrug-Resistant Bacterium Infections After Rigid Internal Fixation of Mandibular Fracture. Journal of Oral and Maxillofacial Surgery. 74(4). 770–777. 7 indexed citations
19.
Jenkins, David W., Sarah J. Ross, Margaret H. Veldman-Jones, et al.. (2012). MEDI0639: A Novel Therapeutic Antibody Targeting Dll4 Modulates Endothelial Cell Function and Angiogenesis In Vivo. Molecular Cancer Therapeutics. 11(8). 1650–1660. 47 indexed citations
20.
Peng, Li, Lin Ren, Guijun Dong, et al.. (2010). Wnt5a promotes differentiation of human dental papilla cells. International Endodontic Journal. 43(5). 404–412. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masakatsu Takanashi Breakdown of academic impact, for papers by Liuqing Yang Breakdown of academic impact, for papers by Xue Gao Breakdown of academic impact, for papers by Haiwei Yang Breakdown of academic impact, for papers by Yunpeng Zhang Breakdown of academic impact, for papers by Zhen Wang Breakdown of academic impact, for papers by Damjan Glavač Breakdown of academic impact, for papers by Jie Ding
Rankless by CCL
2026